Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 16/20 | 0.73 |
| ▸ | RXRB | P28702 | 8/20 | 0.66 |
| ▸ | RXRG | P48443 | 7/20 | 0.66 |
| ▸ | RARB | P10826 | 8/20 | 0.55 |
| ▸ | RARG | P13631 | 8/20 | 0.55 |
| ▸ | RARA | P10276 | 6/20 | 0.55 |
| ▸ | HNF4A | P41235 | 1/20 | 0.54 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.52 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6372600 | 0.90 | RXRA (0.60) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL8014653 | 0.86 | RXRA (0.55) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL6910205 | 0.84 | RXRA (1.00) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL7721760 | 0.82 | RXRA (0.71) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL7720651 | 0.81 | RXRA (0.70) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL7720657 | 0.80 | RXRA (1.00) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL1072953 | 0.77 | RXRA (1.00) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL8164387 | 0.77 | RXRA (0.46) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL1072525 | 0.75 | RXRA (1.00) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL8458901 | 0.74 | RARB (0.64) | RXRARXRBRXRGRARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082111-A4 | ASSAY FOR IDENTIFICATION OF COMPOUNDS THAT PROMOTE MELANIN PRODUCTION AND RETINOID-LIKE COMPOUNDS IDENTIFIED BY SAID ASSAY | GALDERMA RES & DEV (FR) | 2004-03-10 | — | — | EP | claimed |
| US-20030113281-A1 | Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2003-06-19 | — | — | US | claimed |
| US-6391287-B1 | STORAGE STABLE COMPOSITIONS | L'OREAL (FR) | 2002-05-21 | — | — | US | claimed |
| EP-1082111-A1 | ASSAY FOR IDENTIFICATION OF COMPOUNDS THAT PROMOTE MELANIN PRODUCTION AND RETINOID-LIKE COMPOUNDS IDENTIFIED BY SAID ASSAY | Galderma Research & Development, S.N.C. (FR) | 2001-03-14 | — | — | EP | claimed |
| EP-1019049-A1 | METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) USING SPECIFIC RETINOID COMPOUNDS | Galderma Research & Development, S.N.C. (FR) | 2000-07-19 | — | — | EP | claimed |
| WO-1999056740-A1 | ASSAY FOR IDENTIFICATION OF COMPOUNDS THAT PROMOTE MELANIN PRODUCTION AND RETINOID-LIKE COMPOUNDS IDENTIFIED BY SAID ASSAY | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 1999-11-11 | — | — | WO | claimed |
| WO-1998042340-A9 | RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS | — | 1999-03-04 | — | — | WO | claimed |
| WO-1998042340-A1 | RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 1998-10-01 | — | — | WO | claimed |
| US-5766610-A | USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1998-06-16 | — | — | US | claimed |
| EP-0679630-B1 | Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses | CIRD GALDERMA (FR) | 1998-05-06 | — | — | EP | claimed |
| US-20030113281-A1 | Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2003-06-19 | — | — | US | disclosed |
| US-6391287-B1 | STORAGE STABLE COMPOSITIONS | L'OREAL (FR) | 2002-05-21 | — | — | US | disclosed |
| US-6162815-A | RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 2000-12-19 | — | — | US | disclosed |
| US-6156788-A | Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 2000-12-05 | — | — | US | disclosed |
| EP-1019049-A1 | METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) USING SPECIFIC RETINOID COMPOUNDS | Galderma Research & Development, S.N.C. (FR) | 2000-07-19 | — | — | EP | disclosed |
| WO-1998042340-A9 | RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS | — | 1999-03-04 | — | — | WO | disclosed |
| WO-1998042340-A1 | RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 1998-10-01 | — | — | WO | disclosed |
| US-5766610-A | USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1998-06-16 | — | — | US | disclosed |
| EP-0679630-B1 | Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses | CIRD GALDERMA (FR) | 1998-05-06 | — | — | EP | disclosed |
| EP-0679630-A1 | Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 1995-11-02 | — | — | EP | disclosed |